PROTEOSTASIS THERAPEUTICS, INC. (74)

Browse by Contract Category

Contracts

Form of Registration Rights Agreement Amendment, dated October 24, 2022 (Filed With SEC on October 24, 2022)
Kineta, Inc. 2020 Equity Incentive Plan (the Kineta 2020 Plan) and associated forms (Filed With SEC on August 29, 2022)
First Amendment to Kineta 2010 Plan (Filed With SEC on August 29, 2022)
First Amendment to Kineta Lease, dated as of August 12, 2011, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Agreement and Plan of Merger, dated June 5, 2022, by and among Yumanity, Kineta and Merger Sub (Filed With SEC on June 6, 2022)
License Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022 (Filed With SEC on March 4, 2022)
Termination Agreement by and between Yumanity Therapeutics, Inc. and MIL 40, LLC dated as of February 28, 2022 (Filed With SEC on March 4, 2022)
Form of Warrant, dated October 24, 2022 (Filed With SEC on October 24, 2022)
Form of Securities Purchase Agreement Amendment, dated October 24, 2022 (Filed With SEC on October 24, 2022)
Kineta, Inc. Amended and Restated 2008 Stock Plan (the Kineta 2008 Plan) and associated forms (Filed With SEC on August 29, 2022)
Kineta, Inc. 2010 Equity Incentive Plan (the Kineta 2010 Plan) and associated forms (Filed With SEC on August 29, 2022)
Second Amendment to Kineta 2010 Plan (Filed With SEC on August 29, 2022)
Kineta Lease, dated as of November 19, 2010, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Second Amendment to Kineta Lease, dated as of August 28, 2012, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Third Amendment to Kineta Lease, dated as of February 28, 2013, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Fourth Amendment to Kineta Lease, dated as of June 28, 2016, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Fifth Amendment to Kineta Lease, dated as of June 30, 2020, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (Filed With SEC on August 29, 2022)
Form of Yumanity Support Agreement, dated June 5, 2022, by and among Kineta, Yumanity and each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
Asset Purchase Agreement, dated June 5, 2022, by and among Yumanity and Janssen (Filed With SEC on June 6, 2022)
Form of Kineta Support Agreement, dated June 5, 2022, by and among Yumanity, Kineta and each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
Form of Securities Purchase Agreement, dated June 5, 2022, by each of the parties named therein (Filed With SEC on June 6, 2022)
Form of Registration Rights Agreement, dated June 5, 2022, by each of the parties named therein (Filed With SEC on June 6, 2022)
Form of Lock-up Agreement, dated June 5, 2022, by each of the parties named in each agreement therein (Filed With SEC on June 6, 2022)
Lease Termination Agreement by and between Yumanity Therapeutics, Inc. and Ice Box, LLC dated as of May 16, 2022 (Filed With SEC on May 18, 2022)
Separation Agreement by and between Yumanity Therapeutics, Inc. and Paulash Mohsen dated as of March 14, 2022 (Filed With SEC on May 12, 2022)
Separation Agreement by and between Yumanity Therapeutics, Inc. and Ajay Verma, dated as of February 9, 2022 (Filed With SEC on May 12, 2022)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2022)
Employment Offer Letter by and between Yumanity Therapeutics, Inc. and Michael D. Wyzga, dated July 12, 2021 (redacted) (Filed With SEC on August 16, 2021)
D. Smith Offer Letter (redacted) (Filed With SEC on August 12, 2021)
A. Verma Offer Letter (redacted) (Filed With SEC on August 12, 2021)
Sixth Amendment and Consent to Loan and Security Agreement dated as of April 13, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc (Filed With SEC on August 12, 2021)
Fifth Amendment and Consent to Loan and Security Agreement dated as of March 29, 2021, by and among Yumanity, Inc., the lenders party thereto and Hercules Capital, Inc (Filed With SEC on May 13, 2021)
Open Market Sale Agreement SM, dated April 8, 2021, by and between Yumanity Therapeutics, Inc., and Jefferies LLC (Filed With SEC on April 8, 2021)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 31, 2021)
Amended and Restated Warrant Agreement to Purchase Common Stock of the Company issued to Hercules Capital, Inc., dated December 22, 2020 (Filed With SEC on March 31, 2021)
Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan and forms of award agreements thereunder (Filed With SEC on December 30, 2020)
Form of Director and Officer Indemnification Agreements (Filed With SEC on December 30, 2020)
Fourth Amendment and Consent to Loan and Security Agreement dated as of December 22, 2020, by and among Yumanity, Inc. (formerly Yumanity Therapeutics, Inc.), the lenders party... (Filed With SEC on December 30, 2020)
Unconditional Secured Guaranty and Pledge Agreement, dated December 22, 2020 by and between the Company (formerly known as Proteostasis Therapeutics, Inc.) and Hercules Capital,... (Filed With SEC on December 30, 2020)
Contingent Value Rights Agreement, dated as of December 22, 2020 by and among the Company and Shareholder Representative Services LLC (Filed With SEC on December 30, 2020)
Registration Rights Agreement, dated as of December 22, 2020 by among the Company (formerly known as Proteostasis Therapeutics, Inc.) and certain purchasers listed therein (Filed With SEC on December 30, 2020)
Form of Registration Rights Agreement (Filed With SEC on December 15, 2020)
Subscription Agreement, dated as of December 14, 2020 by and among Proteostasis Therapeutics, Inc. and the Purchasers named therein (Filed With SEC on December 15, 2020)
First Amendment to Merger Agreement, dated November 6, 2020, by and among PTI, Yumanity, Holdings and Merger Sub (Filed With SEC on November 6, 2020)
Tangible Property and Exclusive Patent License Agreement, by and between Yumanity Therapeutics, Inc., Yumanity Holdings, LLC and Whitehead Institute for Biomedical Research, dated... (Filed With SEC on September 23, 2020)
U.S. Small Business Administration Paycheck Protection Program Note with Silicon Valley Bank, dated as of April 24, 2020 (Filed With SEC on September 23, 2020)
Form of Support Agreement, by and between Proteostasis Therapeutics, Inc., Yumanity Therapeutics, Inc. and Yumanity Holdings, LLC (Filed With SEC on September 23, 2020)
Loan and Security Agreement, by and among Yumanity Therapeutics, Inc. and Hercules Capital, Inc., dated as December 20, 2019 (Filed With SEC on September 23, 2020)
Warrant Agreement to Purchase Preferred Units of Yumanity Holdings, LLC issued to Hercules Capital, Inc., dated December 20, 2019 (Filed With SEC on September 23, 2020)
License Agreement, by and between Yumanity Therapeutics, Inc. and MIL 40G LLC, dated as of February 5, 2020 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Alexandria Equities, LLC (as predecessor to Alexandria Venture Investments, LLC) on October 9, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Redmile Capital Offshore II Master Fund, Ltd. on August 14, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to Redmile Biotechnologies Investments I AF, LP (as predecessor to Redmile Biopharma Investments I, L.P.) on August 14, 2015 (Filed With SEC on September 23, 2020)
Common Unit Warrant issued to N. Anthony Coles on August 14, 2015 (Filed With SEC on September 23, 2020)
Warrant to Purchase Limited Liability Company Interests issued to Silicon Valley Bank on June 14, 2018 (Filed With SEC on September 23, 2020)
Warrant to Purchase Limited Liability Company Interests issued to Oxford Finance LLC dated June 14, 2018 (Filed With SEC on September 23, 2020)
Agreement and Plan of Merger and Reorganization, dated August 22, 2020, by and among PTI, Yumanity, Holdings and Merger Sub (Filed With SEC on August 24, 2020)
Form of CVR Agreement by and between PTI and the CVR Rep (Filed With SEC on August 24, 2020)
Form of PTI Support Agreement, dated August 22, 2020, by and between Yumanity, PTI and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of Yumanity Support Agreement, dated August 22, 2020, by and between PTI, Yumanity and each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of PTI Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of Yumanity Lock-Up Agreement, dated August 22, 2020, by each of the parties named in each agreement therein (Filed With SEC on August 24, 2020)
Form of Executive Employment Agreement (Filed With SEC on March 10, 2020)
Form of Amended and Restated Executive Agreement (Filed With SEC on March 10, 2020)
Amended and Restated Employment Agreement between the Registrant and Marija Zecevic, dated March 9, 2020 (Filed With SEC on March 10, 2020)
Amended and Restated Employment Agreement between the Registrant and Ben Munoz, dated March 9, 2020 (Filed With SEC on March 10, 2020)
Description of Securities Registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 10, 2020)
Consulting Agreement between the Company and Po-Shun Lee, dated as of July 23, 2019 (Filed With SEC on November 7, 2019)
Separation Agreement and General Release between the Company and Po-Shun Lee, dated as of July 22, 2019 (Filed With SEC on November 7, 2019)
Sales Agreement dated May 9, 2019 by and between Proteostasis Therapeutics, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 9, 2019)
Technology Transfer and License Agreement between the Company and Genentech, Inc., dated December 13, 2018 (Filed With SEC on March 8, 2019)
Employment Agreement between the Company and Sheila Wilson, dated as of May 18, 2017 (Filed With SEC on March 8, 2019)
Assignment and Release Agreement between the Company and Cystic Fibrosis Foundation, dated December 19, 2018 (Filed With SEC on March 8, 2019)
Employment Agreement between the Company and Marija Zecevic, dated as of March 8, 2017 (Filed With SEC on March 8, 2019)